Mitoxantrone Terminated Phase 2 Trials for Prostatic Neoplasms Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00477087Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer
NCT00447473Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer